On the occasion of World Pancreatic Cancer Day, held on 19 November, Clínic Barcelona is supporting the 12th Cities Race against Pancreatic Cancer, an initiative that turns public participation into resources for research.
In recent years, research has opened up new opportunities for these patients, with targeted therapies and specific oral drugs. The organising bodies are calling for this innovation to reach patients swiftly once it has been approved in Europe, and for access to be equitable across the country.
"We are facing a new therapeutic landscape in pancreatic cancer. We must work to make innovation accessible to patients while continuing to carry out research to improve their survival," says Dr Teresa Macarulla, Head of the Medical Oncology Department at Hospital Clínic de Barcelona.
Every bib for research
All proceeds from race bibs and donations go to the Carmen Delgado / Miguel Pérez-Mateo Research Grants. Over its editions, the Cities Race has brought together more than 83,000 participants and raised nearly €1.5 million, funding 20 scientific projects in Spain.
In addition to Barcelona, this year the race is being held in Vigo, Vilamartín de Valdeorras, Alicante, Madrid and Santiago de Compostela. People who wish to contribute without running or walking can do so through the "Dorsal Fila 0" (Row 0 bib).
Registration is open at www.carreracancerpancreas.es.